Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Competitive antagonism of recombinant P2X(2/3) receptors by 2', 3'-O-(2,4,6-trinitrophenyl) adenosine 5'-triphosphate (TNP-ATP).

Burgard EC, Niforatos W, van Biesen T, Lynch KJ, Kage KL, Touma E, Kowaluk EA, Jarvis MF.

Mol Pharmacol. 2000 Dec;58(6):1502-10.

2.

Inhibition mechanism of the recombinant rat P2X(2) receptor in glial cells by suramin and TNP-ATP.

Trujillo CA, Nery AA, Martins AH, Majumder P, Gonzalez FA, Ulrich H.

Biochemistry. 2006 Jan 10;45(1):224-33.

PMID:
16388598
3.

Characterization of cultured dorsal root ganglion neuron P2X receptors.

Grubb BD, Evans RJ.

Eur J Neurosci. 1999 Jan;11(1):149-54.

PMID:
9987019
4.

Agonist-dependence of recovery from desensitization of P2X(3) receptors provides a novel and sensitive approach for their rapid up or downregulation.

Sokolova E, Skorinkin A, Fabbretti E, Masten L, Nistri A, Giniatullin R.

Br J Pharmacol. 2004 Mar;141(6):1048-58. Epub 2004 Feb 23.

5.
6.

P2X purinoceptors in cultured myenteric neurons of guinea-pig small intestine.

Zhou X, Galligan JJ.

J Physiol. 1996 Nov 1;496 ( Pt 3):719-29.

7.

Identification of P2X receptors in cultured mouse and rat parasympathetic otic ganglion neurones including P2X knockout studies.

Ma B, Ruan HZ, Cockayne DA, Ford AP, Burnstock G, Dunn PM.

Neuropharmacology. 2004 Jun;46(7):1039-48.

PMID:
15081800
8.

Pharmacological characterization of recombinant human and rat P2X receptor subtypes.

Bianchi BR, Lynch KJ, Touma E, Niforatos W, Burgard EC, Alexander KM, Park HS, Yu H, Metzger R, Kowaluk E, Jarvis MF, van Biesen T.

Eur J Pharmacol. 1999 Jul 2;376(1-2):127-38.

PMID:
10440098
9.

2', 3'-O-(2,4,6,trinitrophenyl)-ATP and A-317491 are competitive antagonists at a slowly desensitizing chimeric human P2X3 receptor.

Neelands TR, Burgard EC, Uchic ME, McDonald HA, Niforatos W, Faltynek CR, Lynch KJ, Jarvis MF.

Br J Pharmacol. 2003 Sep;140(1):202-10. Epub 2003 Jul 29.

10.

Sensitization by extracellular Ca(2+) of rat P2X(5) receptor and its pharmacological properties compared with rat P2X(1).

Wildman SS, Brown SG, Rahman M, Noel CA, Churchill L, Burnstock G, Unwin RJ, King BF.

Mol Pharmacol. 2002 Oct;62(4):957-66.

11.

TNP-ATP-resistant P2X ionic current on the central terminals and somata of rat primary sensory neurons.

Tsuzuki K, Ase A, Séguéla P, Nakatsuka T, Wang CY, She JX, Gu JG.

J Neurophysiol. 2003 Jun;89(6):3235-42.

12.

Properties of the novel ATP-gated ionotropic receptor composed of the P2X(1) and P2X(5) isoforms.

Haines WR, Torres GE, Voigt MM, Egan TM.

Mol Pharmacol. 1999 Oct;56(4):720-7.

13.

The suramin analogue NF279 is a novel and potent antagonist selective for the P2X(1) receptor.

Rettinger J, Schmalzing G, Damer S, Müller G, Nickel P, Lambrecht G.

Neuropharmacology. 2000 Aug 23;39(11):2044-53.

PMID:
10963748
14.

P2X receptor-mediated ionic currents in dorsal root ganglion neurons.

Burgard EC, Niforatos W, van Biesen T, Lynch KJ, Touma E, Metzger RE, Kowaluk EA, Jarvis MF.

J Neurophysiol. 1999 Sep;82(3):1590-8.

16.

Identification of P1 and P2 purinoceptors in the aorta of the lizard (Agama sp.).

Knight GE, Burnstock G.

Comp Biochem Physiol C Toxicol Pharmacol. 2001 Mar;128(3):413-23.

PMID:
11255114
17.

TNP-ATP, a potent P2X3 receptor antagonist, blocks acetic acid-induced abdominal constriction in mice: comparison with reference analgesics.

Honore P, Mikusa J, Bianchi B, McDonald H, Cartmell J, Faltynek C, Jarvis MF.

Pain. 2002 Mar;96(1-2):99-105.

PMID:
11932066
18.

Expression and function of P2X purinoceptors in rat histaminergic neurons.

Vorobjev VS, Sharonova IN, Haas HL, Sergeeva OA.

Br J Pharmacol. 2003 Mar;138(5):1013-9.

19.

Osteoblast responses to nucleotides increase during differentiation.

Orriss IR, Knight GE, Ranasinghe S, Burnstock G, Arnett TR.

Bone. 2006 Aug;39(2):300-9. Epub 2006 Apr 17.

PMID:
16616882
20.

[3H]A-317491, a novel high-affinity non-nucleotide antagonist that specifically labels human P2X2/3 and P2X3 receptors.

Jarvis MF, Bianchi B, Uchic JT, Cartmell J, Lee CH, Williams M, Faltynek C.

J Pharmacol Exp Ther. 2004 Jul;310(1):407-16. Epub 2004 Mar 15.

Supplemental Content

Support Center